AstraZeneca Buys 20 Stake in Cambridge Antibody (Update1) AstraZeneca Plc, the UK #39;s second biggest drugmaker, bought a 19.9 percent stake in Cambridge Antibody Technology Group Plc, an unprofitable biotechnology company, for 75 million pounds (\$139 million).